{
    "nctId": "NCT02013726",
    "briefTitle": "MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue",
    "officialTitle": "Pilot Study: Dedicated Dual Head Molecular Breast Imaging Compared to Breast Tomosynthesis for Evaluation of Patients With Type 3 or 4 Mammographic Breast Density",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Sensitivity/Cancer detection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women over 25 years of age with normal or increased risk of breast cancer.\n* Women with type 3 or 4 breast density as determined by a breast imaging radiologist on a current unilateral (women with prior mastectomy) or bilateral mammography (within prior 6 weeks).\n* No contraindications to breast MBI or breast tomosynthesis.\n\nExclusion Criteria:\n\n* Women under the age of 25.\n* Women who are or may be pregnant.\n* Women who are currently lactating or have discontinued breast feeding \\< 2 months prior to the study.\n* Male patients are excluded as subjects.\n* Those unable or unwilling to provide informed consent.",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}